Piramal Pharma Ltd - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
12 Jul 2024
Successful closure of US FDA Inspection at Piramal Pharma''s manufacturing facility located at Ahmedabad.
Source:
BSE India